Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

REMUS PHARMA vs MISHKA EXIM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    REMUS PHARMA MISHKA EXIM REMUS PHARMA/
MISHKA EXIM
 
P/E (TTM) x - 183.2 - View Chart
P/BV x 16.5 4.2 395.4% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 REMUS PHARMA   MISHKA EXIM
EQUITY SHARE DATA
    REMUS PHARMA
Mar-24
MISHKA EXIM
Mar-24
REMUS PHARMA/
MISHKA EXIM
5-Yr Chart
Click to enlarge
High Rs7,89583 9,458.4%   
Low Rs2,95028 10,535.7%   
Sales per share (Unadj.) Rs1,445.62.8 51,298.1%  
Earnings per share (Unadj.) Rs176.70.2 100,138.1%  
Cash flow per share (Unadj.) Rs182.80.3 66,707.0%  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs590.915.0 3,949.1%  
Shares outstanding (eoy) m1.4714.45 10.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.819.8 19.0%   
Avg P/E ratio x30.7316.1 9.7%  
P/CF ratio (eoy) x29.7203.4 14.6%  
Price / Book Value ratio x9.23.7 246.9%  
Dividend payout %3.40-   
Avg Mkt Cap Rs m7,987805 991.8%   
No. of employees `000NANA-   
Total wages/salary Rs m741 7,896.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,12541 5,218.6%  
Other income Rs m543 1,636.4%   
Total revenues Rs m2,17944 4,950.0%   
Gross profit Rs m2782 11,684.9%  
Depreciation Rs m91 635.5%   
Interest Rs m50 1,861.5%   
Profit before tax Rs m3184 7,937.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m591 4,008.2%   
Profit after tax Rs m2603 10,187.1%  
Gross profit margin %13.15.8 224.2%  
Effective tax rate %18.436.5 50.4%   
Net profit margin %12.26.3 195.4%  
BALANCE SHEET DATA
Current assets Rs m2,09749 4,283.9%   
Current liabilities Rs m1,4951 138,409.3%   
Net working cap to sales %28.4117.6 24.1%  
Current ratio x1.445.3 3.1%  
Inventory Days Days641,492 4.3%  
Debtors Days Days1,966122,655 1.6%  
Net fixed assets Rs m467189 247.4%   
Share capital Rs m15145 10.2%   
"Free" reserves Rs m85472 1,190.9%   
Net worth Rs m869216 401.7%   
Long term debt Rs m300-   
Total assets Rs m2,564238 1,078.9%  
Interest coverage x66.816.4 406.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.2 483.7%   
Return on assets %10.31.2 874.5%  
Return on equity %29.91.2 2,538.3%  
Return on capital %36.02.0 1,821.9%  
Exports to sales %00-   
Imports to sales %0.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m8NA-   
Fx inflow Rs m6150-   
Fx outflow Rs m260-   
Net fx Rs m5890-   
CASH FLOW
From Operations Rs m361 6,210.3%  
From Investments Rs m-892 -4,886.9%  
From Financial Activity Rs m244-4 -6,787.2%  
Net Cashflow Rs m190-1 -16,123.7%  

Share Holding

Indian Promoters % 70.8 50.4 140.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.9 0.0 -  
FIIs % 3.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.2 49.6 58.8%  
Shareholders   1,753 638 274.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare REMUS PHARMA With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    MSTC    


More on REMUS PHARMA vs MISHKA EXIM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

REMUS PHARMA vs MISHKA EXIM Share Price Performance

Period REMUS PHARMA MISHKA EXIM S&P BSE OIL & GAS
1-Day 2.75% -0.24% 3.26%
1-Month 0.84% -1.27% -3.44%
1-Year -55.43% 77.86% 31.98%
3-Year CAGR -8.88% 21.51% 12.87%
5-Year CAGR -5.42% 12.21% 11.92%

* Compound Annual Growth Rate

Here are more details on the REMUS PHARMA share price and the MISHKA EXIM share price.

Moving on to shareholding structures...

The promoters of REMUS PHARMA hold a 70.8% stake in the company. In case of MISHKA EXIM the stake stands at 50.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of REMUS PHARMA and the shareholding pattern of MISHKA EXIM.

Finally, a word on dividends...

In the most recent financial year, REMUS PHARMA paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 3.4%.

MISHKA EXIM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of REMUS PHARMA, and the dividend history of MISHKA EXIM.



Today's Market

Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.